NSE: HESTERBIO | BSE: 524669

Mid-range Performer

Download real time

1671.80 -23.50 (-1.39%)

39.60% Fall from 52W High

2,336 NSE+BSE Volume

NSE 21 Nov, 2025 3:31 PM (IST)

1,422.2

Market Cap

Above industry Median

0.8

Beta 1Year

Very Low volatility

Hester Biosciences Ltd. share price target and research reports

Name: Latest research reports of Hester Biosciences Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: Hester Biosciences Ltd.
Rating: 1
Author: ICICI Direct

Latest analyst research reports with target prices and PDF download for HESTERBIO, BSE:524669 Hester Biosciences Ltd.

Search Inside the pdf :

Hester Biosciences Ltd.

18 May 2023

1671.80

-1.39%

Hester Biosciences

Sell: Hester Biosciences Ltd.

Recommendation Target

ICICI Direct

Hester Biosciences Ltd. has lost -29.81% in the last 1 Year

Hester Biosciences Ltd.

02 Feb 2023

1671.80

-1.39%

Hester Biosciences

Hold: Hester Biosciences Ltd.

Target

ICICI Direct

Hester Biosciences Ltd. is trading above its 30 day SMA of 1671.0

Hester Biosciences Ltd.

08 Nov 2022

1671.80

-1.39%

Hester Biosciences

Hold: Hester Biosciences Ltd.

Recommendation Target

ICICI Direct

Hester Biosciences Ltd. has lost -29.81% in the last 1 Year

Hester Biosciences Ltd.

16 Aug 2022

1671.80

-1.39%

Hester Biosciences

Sell: Hester Biosciences Ltd.

Recommendation Target

ICICI Direct

Hester Biosciences Ltd. is trading below its 50 day SMA of 1786.5

Hester Biosciences Ltd.

23 May 2022

1671.80

-1.39%

Hester Biosciences

Hold: Hester Biosciences Ltd.

ICICI Direct

Hester Biosciences Ltd. is trading above its 30 day SMA of 1671.0

Hester Biosciences Ltd.

02 Feb 2022

1671.80

-1.39%

Hester Biosciences

Hold: Hester Biosciences Ltd.

Target

ICICI Securities Limited

Revenue segment wise: poultry healthcare:73%, animal healthcare: 19%, others:8%; by geography: domestic:81%, exports:10%, others:9% Q3FY22 Results: Numbers were impacted by base effect....

Hester Biosciences Ltd. is trading below its 50 day SMA of 1786.5

Hester Biosciences Ltd.

13 Aug 2021

1671.80

-1.39%

Hester Biosciences

Hold: Hester Biosciences Ltd.

Target

ICICI Securities Limited

Hester Biosciences Ltd. has lost -29.81% in the last 1 Year

Hester Biosciences Ltd.

09 Jun 2021

1671.80

-1.39%

Hester Biosciences

Hold: Hester Biosciences Ltd.

Target

ICICI Securities Limited

Despite exports being impacted by air shipment restrictions due to Covid, Hester ended FY21 on a relatively strong note amid strong demand for poultry vaccines and health products in domestic market. Going ahead, opportunities panning out from animal vaccines such as classical swine fever, lumpy skin disease (only player) and sheep pox (only player) in the domestic space besides increased focus on health products, growth prospects look promising for Hester. Additionally, the management intends to move away from preventive healthcare to curative healthcare as a long...

Hester Biosciences Ltd. has lost -29.81% in the last 1 Year

Hester Biosciences Ltd.

31 Oct 2020

1671.80

-1.39%

Hester Biosciences

Hold: Hester Biosciences Ltd.

Target

ICICI Securities Limited

After witnessing muted performances in the last few quarters, first on account of maize price issues affecting poultry vaccines and then the Covid related disturbances, the Q2 performance witnessed a substantial revival. Going ahead, opportunities panning out from PPR, Brucella vaccine tenders being floated in near term besides increased focus on health products, growth prospects looks promising for animal segment. That said, higher dependence on poultry segment and mostly tenderised nature of animal vaccine segment in the domestic market continue to influence...

Hester Biosciences Ltd. is trading above its 30 day SMA of 1671.0

Hester Biosciences Ltd.

28 Jun 2020

1671.80

-1.39%

Hester Biosciences

Hold: Hester Biosciences Ltd.

Recommendation Target

ICICI Securities Limited

The poultry vaccine business faced significant headwinds in FY20 as a sharp spike in maize prices (accounting for ~50% of feed cost) hampered the vaccination drive among poultry farmers. Just when things were returning to normalcy, came the Covid disturbance. Uncertainty remains upon normalisation of chicken, egg consumption pattern to pre-Covid level. The animal health segment, on the other hand, is expected to remain strong due to tenders and strong export potential. However, fortunes in the poultry segment would continue to weigh on sentiments. We arrive at a...

Hester Biosciences Ltd. has lost -29.81% in the last 1 Year

Is Hester Biosciences Ltd. worth buying?

81 Votes:

Buy 80.25%

Sell 11.11%

Hold 8.64%